Patents by Inventor Luis Gustavo Pérez Rivas

Luis Gustavo Pérez Rivas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microrna signature as an indicator of the risk of early recurrence in patients with breast cancer
    Patent number: 10059998
    Abstract: The invention relates to the field of oncology and cancer treatment. The invention relates to methods for predicting the risk of recurrence of breast tumors using the expression signature of particular miRNAs. Specifically, the invention relates to a method for determining the risk of recurrence of breast cancer which comprises measuring the expression levels of at least one miRNA selected from the group consisting of miR-149-5p (SEQ ID NO: 1), miR-10a-5p, (SEQ ID NO: 2), miR-20b-5p, (SEQ ID NO: 3), miR-30a-3p (SEQ ID NO: 4), and miR-342-5p, (SEQ ID NO: 5) in a sample of the tumor, wherein a change in the expression level of at least one miRNA in the tumor with respect to the expression level in a control sample is indicative of a high risk of recurrence of the tumor. The invention also relates to tools and kits for carrying out the method of the invention.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: August 28, 2018
    Assignees: Servicio Andaluz de Salud, Fundacion Publica Andaluza para la Investigacion de Malaga en Biomedicina y Salud (FIMABIS), Universidad de Malaga
    Inventors: José Lozano Castro, Emilio Alba Conejo, Luis Gustavo Pérez Rivas, José Jerez Aragonés, Nuria Ribelles Entrena
  • MICRORNA SIGNATURE AS AN INDICATOR OF THE RISK OF EARLY RECURRENCE IN PATIENTS WITH BREAST CANCER
    Publication number: 20170002424
    Abstract: The invention relates to the field of oncology and cancer treatment. The invention relates to methods for predicting the risk of recurrence of breast tumors using the expression signature of particular miRNAs. Specifically, the invention relates to a method for determining the risk of recurrence of breast cancer which comprises measuring the expression levels of at least one miRNA selected from the group consisting of miR-149-5p (SEQ ID NO: 1), miR-10a-5p, (SEQ ID NO: 2), miR-20b-5p, (SEQ ID NO: 3), miR-30a-3p (SEQ ID NO: 4), and miR-342-5p, (SEQ ID NO: 5) in a sample of the tumor, wherein a change in the expression level of at least one miRNA in the tumor with respect to the expression level in a control sample is indicative of a high risk of recurrence of the tumor. The invention also relates to tools and kits for carrying out the method of the invention.
    Type: Application
    Filed: March 13, 2015
    Publication date: January 5, 2017
    Inventors: José Lozano Castro, Emilio Alba Conejo, Luis Gustavo Pérez Rivas, José Jerez Aragonés, Nuria Ribelles Entrena